Get the Stockscreener App
6.89
4.97%
-0.36
After Hours:
7.04
0.15
+2.18%
Terns Pharmaceuticals Inc stock is traded at $6.89, with a volume of 1.27M.
It is down -4.97% in the last 24 hours and up +13.88% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$7.25
Open:
$7.24
24h Volume:
1.27M
Relative Volume:
1.29
Market Cap:
$602.95M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-5.2197
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+9.37%
1M Performance:
+13.88%
6M Performance:
+86.72%
1Y Performance:
-13.33%
1-Day Range:
$6.87
$7.32
1-Week Range:
$6.2324
$7.32
52-Week Range:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
6.89 | 634.46M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
Terns Pharmaceuticals Inc. recovery potential after sell off2025 Trading Recap & Growth Focused Entry Reports - Newser
Sentiment analysis tools applied to Terns Pharmaceuticals Inc.2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Key metrics from Terns Pharmaceuticals Inc.’s quarterly dataChart Signals & Daily Entry Point Alerts - Newser
Terns Pharmaceuticals Inc. stock daily chart insightsRate Hike & Fast Entry Momentum Trade Alerts - Newser
Custom strategy builders for tracking Terns Pharmaceuticals Inc.Weekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Can trapped investors hope for a rebound in Terns Pharmaceuticals Inc.Portfolio Value Summary & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-26 09:40:00 - Newser
Terns Pharmaceuticals Inc. stock chart pattern explainedPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
Analyzing Terns Pharmaceuticals Inc. with risk reward ratio chartsFed Meeting & Comprehensive Market Scan Reports - Newser
Published on: 2025-08-25 23:36:00 - Newser
AI Indicators Detect Buy Opportunity in Terns Pharmaceuticals Inc.July 2025 Snapshot & Growth Focused Investment Plans - beatles.ru
Published on: 2025-08-25 21:55:06 - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - Newser
Multi asset correlation models including Terns Pharmaceuticals Inc.July 2025 Catalysts & Growth Focused Entry Point Reports - Newser
What is the target price for Terns Pharmaceuticals Inc. stockCEO Change & Safe Entry Point Identification - theviewers.co.kr
Is Terns Pharmaceuticals Inc. benefiting from innovation trendsDay Trade & Smart Investment Allocation Insights - theviewers.co.kr
Technical Charts Suggest Momentum Shift in Terns Pharmaceuticals Inc.July 2025 Opening Moves & Community Verified Trade Signals - beatles.ru
Published on: 2025-08-22 19:49:45 - beatles.ru
Momentum Indicator Shows Bearish Divergence in Terns Pharmaceuticals Inc.July 2025 Movers & Risk Controlled Swing Alerts - beatles.ru
How do insiders feel about Terns Pharmaceuticals Inc.Market Activity Recap & Fast Moving Stock Trade Plans - kpenews.com
Terns Pharmaceuticals to Host an Educational Webinar on - GlobeNewswire
Terns Pharmaceuticals to host investor webinar on TERN-701 for CML By Investing.com - Investing.com
Next-Gen CML Treatment: Terns Pharma to Preview TERN-701 Phase 1 Data in Special Investor Session - Stock Titan
What institutional flow reveals about Terns Pharmaceuticals Inc.July 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Disappointing Oral GLP-1 Data Creates Opportunity for Terns Pharmaceuticals - AInvest
RSI Suggests Rebound May Be Near in Terns Pharmaceuticals Inc.CEO Change & Safe Entry Trade Reports - newsyoung.net
Terns Pharmaceuticals Inc. Nearing Breakout Level After BounceJuly 2025 Closing Moves & AI Driven Price Forecasts - 더경남뉴스
Institutional Tools Highlight Unusual Flow in Terns Pharmaceuticals Inc.July 2025 Momentum & Real-Time Volume Triggers - beatles.ru
Analyzing drawdowns of Terns Pharmaceuticals Inc. with statistical toolsJuly 2025 PreEarnings & Weekly High Momentum Picks - Newser
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.July 2025 Price Swings & Consistent Growth Equity Picks - Newser
Best data tools to analyze Terns Pharmaceuticals Inc. stockMarket Sentiment Review & Growth Focused Investment Plans - Newser
Using AI based signals to follow Terns Pharmaceuticals Inc.July 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Is Terns Pharmaceuticals Inc. stock bottoming outJuly 2025 Spike Watch & High Yield Stock Recommendations - Newser
Is Terns Pharmaceuticals Inc. a play on infrastructure spendingWeekly Profit Report & Free Safe Capital Growth Stock Tips - thegnnews.com
Will earnings trigger a reversal in Terns Pharmaceuticals Inc.Weekly Investment Summary & Free Long-Term Investment Growth Plans - Newser
Terns Pharmaceuticals Inc. At Critical Juncture — Bounce or BreakdownPortfolio Profit Report & Technical Pattern Recognition Alerts - metal.it
Terns Pharmaceuticals Inc (TERN) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Is It Too Late to Sell Terns Pharmaceuticals Inc.2025 Market Sentiment & Real-Time Market Sentiment Reports - classian.co.kr
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data - Investing.com Nigeria
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data By Investing.com - Investing.com South Africa
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):